OraSure Technologies, Inc.

Informe acción NasdaqGS:OSUR

Capitalización de mercado: US$289.4m

OraSure Technologies Resultados de beneficios anteriores

Pasado controles de criterios 1/6

OraSure Technologies ha aumentado sus beneficios a una tasa media anual de 21.8%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 12% anual. Los ingresos han ido creciendo a una tasa media de 19.1% al año. La rentabilidad financiera de OraSure Technologies es de 2.7%, y sus márgenes netos son de 5.1%.

Información clave

21.8%

Tasa de crecimiento de los beneficios

19.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment 8.9%
Tasa de crecimiento de los ingresos19.1%
Rentabilidad financiera2.7%
Margen neto5.1%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14
Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Recent updates

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14
Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

Nov 08
Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

OraSure: An NCAV Diamond In The COVID Rough

Nov 04

OraSure Technologies: Nursing A COVID-19 Hangover

Sep 10

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

May 11
OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Apr 17
Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01
Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20
OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08
Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09
Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16
Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17
Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Jan 16
We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

OraSure wins $8.6M government contract for next-gen Ebola test

Sep 28

OraSure: Revenue Mix Continues To Present Risk

Sep 06

Biden administration ending free at-home COVID tests due to lack of funding

Aug 29

Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Aug 11
Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14
Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

Jun 10

Desglose de ingresos y gastos

Cómo gana y gasta dinero OraSure Technologies. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:OSUR Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 24224117826
30 Jun 24274277930
31 Mar 24305238431
31 Dec 23405549233
30 Sep 23453499934
30 Jun 234804410936
31 Mar 234753011338
31 Dec 22387-1711736
30 Sep 22328-4311837
30 Jun 22265-6411536
31 Mar 22243-4710734
31 Dec 21234-239534
30 Sep 21233-118936
30 Jun 2122758035
31 Mar 21199-47934
31 Dec 20172-157731
30 Sep 20158-147427
30 Jun 20146-27223
31 Mar 20156136721
31 Dec 19155176520
30 Sep 19150257318
30 Jun 19159207017
31 Mar 19161196917
31 Dec 18182206916
30 Sep 18177175716
30 Jun 18174155715
31 Mar 18174165814
31 Dec 17166315813
30 Sep 17145316010
30 Jun 17135315910
31 Mar 17126305710
31 Dec 16123205810
30 Sep 16125175811
30 Jun 16123126110
31 Mar 16122116210
31 Dec 1512086111
30 Sep 1511616312
30 Jun 1511416113
31 Mar 1511016212
31 Dec 14106-56512
30 Sep 1410746610
30 Jun 1410316510
31 Mar 14101-7679
31 Dec 1399-116910

Ingresos de calidad: OSUR tiene una única gran pérdida de $17.2M que afecta a sus resultados financieros de los últimos 12 meses de 30th September, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(5.1%) de OSUR son inferiores a los del año pasado (10.9%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lOSUR han crecido significativamente en un 21.8% al año.

Acelerando crecimiento: OSUR ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: OSUR tuvo un crecimiento negativo de los beneficios (-77%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (10.4%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de OSUR (2.7%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado